News
Melbourne Pharma is redefining healthcare for Gen Z in Florida with personalized compounded medications for skincare, mental health, hormone balance, and more! MELBOURNE, FL, UNITED STATES ...
COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ...
Imperial Brands said CEO Stefan Bomhard will retire after five years in the job, sending the British cigarette maker's shares ...
The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment ...
Ascendis Pharma A/S announced positive results from Week 214 of its Phase 2 PaTH Forward Trial, indicating that long-term treatment with TransCon PTH (palopegteriparatide) effectively maintains a ...
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment ...
LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with ...
Investing.com - Global pharmaceutical stocks were mixed Monday after U.S. President Donald Trump signed an executive order aimed at reducing prescription drug prices in the United States by ...
"It validates our technology platform amid the growing demand for comprehensive intelligence solutions in the pharmaceutical and biotech sectors, reaffirming our commitment to innovation and ...
Plus, hear exclusive interviews from experts, including: Catherine Owen Adams from Acadia Pharmaceuticals on trends and innovations in brain health NKarta’s Paul Hastings discusses natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results